This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China urges EU to revoke public-procurement restrictions, opposes unilateral barriers

( June 24, 2025, 07:19 GMT | Official Statement) -- MLex Summary: China's Ministry of Commerce has urged the EU to revoke restrictions announced on June 20 targeting Chinese medical-device makers in EU public-procurement contracts, according to a ministry spokesperson's statement today. Highlighting that the EU has been creating ongoing obstacles in public procurement and investment for Chinese companies, the ministry accused the EU of disregarding China's goodwill expressed through bilateral dialogue and unilaterally erecting new protectionist barriers, harming Chinese businesses and undermining fair competition. China called on both sides to implement consensus reached by their leaders, resolve trade frictions through dialogue and restore confidence and stability in bilateral business cooperation.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections